Literature DB >> 20684141

Scalp psoriasis: an overview of the disease and available therapies.

Jeffrey Crowley1.   

Abstract

The scalp is one of the regions of the body most commonly affected by psoriatic lesions. While the head represents only 10 percent of the body's surface area, the consequences of scalp psoriasis are disproportionate to the area, as it can be seriously debilitating and presents social and emotional distress to the affected individual. Scalp lesions are often well-demarcated and may have thick gray or white scale; patients with scalp psoriasis frequently complain of pruritus and shedding of scale. Current treatment modalities--including phototherapy, topical corticosteroids, topical vitamin D analogues and conventional systemic therapies--have produced unsatisfactory results for patients with moderate-to-severe scalp psoriasis due to difficulties in administration to the disease site, poor compliance, toxicity and inadequate long-term efficacy. The emergence of biologic therapies as an effective modality for the treatment of plaque psoriasis may provide another option for patients suffering from plaque psoriasis of the scalp.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684141

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

1.  Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Authors:  Arthur Kavanaugh; Philip Helliwell; Christopher T Ritchlin
Journal:  Rheumatol Ther       Date:  2016-02-29

Review 2.  [Psoriasis capitis and seborrhoic eczema of scalp diseases].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

3.  Clinical and Videodermoscopic Evaluation of the Efficacy, Safety, and Tolerability of a Shampoo Containing Ichthyol, Zanthalene, Mandelic Acid, and Honey in the Treatment of Scalp Psoriasis.

Authors:  Maria Mariano; Maria Pia De Padova; Sandra Lorenzi; Norma Cameli
Journal:  Skin Appendage Disord       Date:  2018-02-16

4.  Efficacy and Tolerability of a Shampoo Containing Broad-Spectrum Cannabidiol in the Treatment of Scalp Inflammation in Patients with Mild to Moderate Scalp Psoriasis or Seborrheic Dermatitis.

Authors:  Colombina Vincenzi; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2020-10-19

5.  Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.

Authors:  Leon Kircik; Joseph Fowler; Jonathan Weiss; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30

Review 6.  Management of scalp psoriasis: current perspectives.

Authors:  Kim Blakely; Melinda Gooderham
Journal:  Psoriasis (Auckl)       Date:  2016-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.